nodes	percent_of_prediction	percent_of_DWPC	metapath
Darunavir—Hepatic failure—Hydroxyurea—head and neck cancer	0.00749	0.00749	CcSEcCtD
Darunavir—Renal failure acute—Hydroxyurea—head and neck cancer	0.00729	0.00729	CcSEcCtD
Darunavir—Herpes simplex—Fluorouracil—head and neck cancer	0.00724	0.00724	CcSEcCtD
Darunavir—Inflammation—Fluorouracil—head and neck cancer	0.00688	0.00688	CcSEcCtD
Darunavir—Dermatitis atopic—Docetaxel—head and neck cancer	0.00651	0.00651	CcSEcCtD
Darunavir—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.0063	0.0063	CcSEcCtD
Darunavir—Hepatotoxicity—Docetaxel—head and neck cancer	0.00624	0.00624	CcSEcCtD
Darunavir—Angina pectoris—Vinblastine—head and neck cancer	0.00621	0.00621	CcSEcCtD
Darunavir—Breast disorder—Hydroxyurea—head and neck cancer	0.00608	0.00608	CcSEcCtD
Darunavir—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00607	0.00607	CcSEcCtD
Darunavir—Pancytopenia—Vinblastine—head and neck cancer	0.00606	0.00606	CcSEcCtD
Darunavir—Ageusia—Docetaxel—head and neck cancer	0.00594	0.00594	CcSEcCtD
Darunavir—Rhinorrhoea—Docetaxel—head and neck cancer	0.00594	0.00594	CcSEcCtD
Darunavir—Rigors—Docetaxel—head and neck cancer	0.0059	0.0059	CcSEcCtD
Darunavir—Sepsis—Fluorouracil—head and neck cancer	0.00579	0.00579	CcSEcCtD
Darunavir—Pancreatitis—Hydroxyurea—head and neck cancer	0.0057	0.0057	CcSEcCtD
Darunavir—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00561	0.00561	CcSEcCtD
Darunavir—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00557	0.00557	CcSEcCtD
Darunavir—Myocardial infarction—Vinblastine—head and neck cancer	0.00557	0.00557	CcSEcCtD
Darunavir—Pancytopenia—Hydroxyurea—head and neck cancer	0.00552	0.00552	CcSEcCtD
Darunavir—Neutropenia—Hydroxyurea—head and neck cancer	0.00544	0.00544	CcSEcCtD
Darunavir—Dysuria—Hydroxyurea—head and neck cancer	0.00544	0.00544	CcSEcCtD
Darunavir—Disorientation—Fluorouracil—head and neck cancer	0.00541	0.00541	CcSEcCtD
Darunavir—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.0053	0.0053	CcSEcCtD
Darunavir—Weight increased—Hydroxyurea—head and neck cancer	0.00529	0.00529	CcSEcCtD
Darunavir—Drug interaction—Docetaxel—head and neck cancer	0.00519	0.00519	CcSEcCtD
Darunavir—Infestation NOS—Hydroxyurea—head and neck cancer	0.00519	0.00519	CcSEcCtD
Darunavir—Infestation—Hydroxyurea—head and neck cancer	0.00519	0.00519	CcSEcCtD
Darunavir—Haemoglobin—Vinblastine—head and neck cancer	0.00513	0.00513	CcSEcCtD
Darunavir—Haemorrhage—Vinblastine—head and neck cancer	0.0051	0.0051	CcSEcCtD
Darunavir—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00509	0.00509	CcSEcCtD
Darunavir—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00508	0.00508	CcSEcCtD
Darunavir—Hypoaesthesia—Vinblastine—head and neck cancer	0.00508	0.00508	CcSEcCtD
Darunavir—Stomatitis—Hydroxyurea—head and neck cancer	0.00506	0.00506	CcSEcCtD
Darunavir—Inflammation—Docetaxel—head and neck cancer	0.00497	0.00497	CcSEcCtD
Darunavir—Lethargy—Fluorouracil—head and neck cancer	0.00494	0.00494	CcSEcCtD
Darunavir—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0049	0.0049	CcSEcCtD
Darunavir—Respiratory failure—Docetaxel—head and neck cancer	0.0049	0.0049	CcSEcCtD
Darunavir—Haemoglobin—Hydroxyurea—head and neck cancer	0.00468	0.00468	CcSEcCtD
Darunavir—Haemorrhage—Hydroxyurea—head and neck cancer	0.00466	0.00466	CcSEcCtD
Darunavir—Irritability—Fluorouracil—head and neck cancer	0.00462	0.00462	CcSEcCtD
Darunavir—Alopecia—Vinblastine—head and neck cancer	0.00451	0.00451	CcSEcCtD
Darunavir—Dry skin—Fluorouracil—head and neck cancer	0.00444	0.00444	CcSEcCtD
Darunavir—Neoplasm—Docetaxel—head and neck cancer	0.00435	0.00435	CcSEcCtD
Darunavir—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00433	0.00433	CcSEcCtD
Darunavir—Muscular weakness—Fluorouracil—head and neck cancer	0.00427	0.00427	CcSEcCtD
Darunavir—Angiopathy—Hydroxyurea—head and neck cancer	0.00422	0.00422	CcSEcCtD
Darunavir—Sepsis—Docetaxel—head and neck cancer	0.00418	0.00418	CcSEcCtD
Darunavir—Chills—Hydroxyurea—head and neck cancer	0.00418	0.00418	CcSEcCtD
Darunavir—Eosinophilia—Fluorouracil—head and neck cancer	0.00415	0.00415	CcSEcCtD
Darunavir—Ill-defined disorder—Vinblastine—head and neck cancer	0.00412	0.00412	CcSEcCtD
Darunavir—Alopecia—Hydroxyurea—head and neck cancer	0.00411	0.00411	CcSEcCtD
Darunavir—Anaemia—Vinblastine—head and neck cancer	0.00411	0.00411	CcSEcCtD
Darunavir—Angina pectoris—Fluorouracil—head and neck cancer	0.00408	0.00408	CcSEcCtD
Darunavir—Erythema—Hydroxyurea—head and neck cancer	0.00405	0.00405	CcSEcCtD
Darunavir—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00402	0.00402	CcSEcCtD
Darunavir—Malaise—Vinblastine—head and neck cancer	0.00401	0.00401	CcSEcCtD
Darunavir—Vertigo—Vinblastine—head and neck cancer	0.00399	0.00399	CcSEcCtD
Darunavir—Leukopenia—Vinblastine—head and neck cancer	0.00398	0.00398	CcSEcCtD
Darunavir—Pancytopenia—Fluorouracil—head and neck cancer	0.00398	0.00398	CcSEcCtD
Darunavir—Hepatic failure—Docetaxel—head and neck cancer	0.00389	0.00389	CcSEcCtD
Darunavir—Convulsion—Vinblastine—head and neck cancer	0.00385	0.00385	CcSEcCtD
Darunavir—Hypertension—Vinblastine—head and neck cancer	0.00384	0.00384	CcSEcCtD
Darunavir—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00376	0.00376	CcSEcCtD
Darunavir—Anaemia—Hydroxyurea—head and neck cancer	0.00375	0.00375	CcSEcCtD
Darunavir—Discomfort—Vinblastine—head and neck cancer	0.00374	0.00374	CcSEcCtD
Darunavir—Infestation—Fluorouracil—head and neck cancer	0.00373	0.00373	CcSEcCtD
Darunavir—Infestation NOS—Fluorouracil—head and neck cancer	0.00373	0.00373	CcSEcCtD
Darunavir—Visual disturbance—Docetaxel—head and neck cancer	0.00369	0.00369	CcSEcCtD
Darunavir—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00368	0.00368	CcSEcCtD
Darunavir—Renal impairment—Docetaxel—head and neck cancer	0.00367	0.00367	CcSEcCtD
Darunavir—Myocardial infarction—Fluorouracil—head and neck cancer	0.00366	0.00366	CcSEcCtD
Darunavir—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00366	0.00366	CcSEcCtD
Darunavir—Malaise—Hydroxyurea—head and neck cancer	0.00365	0.00365	CcSEcCtD
Darunavir—Stomatitis—Fluorouracil—head and neck cancer	0.00364	0.00364	CcSEcCtD
Darunavir—Leukopenia—Hydroxyurea—head and neck cancer	0.00363	0.00363	CcSEcCtD
Darunavir—Lethargy—Docetaxel—head and neck cancer	0.00357	0.00357	CcSEcCtD
Darunavir—Thrombocytopenia—Vinblastine—head and neck cancer	0.00355	0.00355	CcSEcCtD
Darunavir—Epistaxis—Fluorouracil—head and neck cancer	0.00352	0.00352	CcSEcCtD
Darunavir—Convulsion—Hydroxyurea—head and neck cancer	0.00351	0.00351	CcSEcCtD
Darunavir—Hyponatraemia—Docetaxel—head and neck cancer	0.00351	0.00351	CcSEcCtD
Darunavir—Pain in extremity—Docetaxel—head and neck cancer	0.0035	0.0035	CcSEcCtD
Darunavir—Anorexia—Vinblastine—head and neck cancer	0.00346	0.00346	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00343	0.00343	CcSEcCtD
Darunavir—Discomfort—Hydroxyurea—head and neck cancer	0.00341	0.00341	CcSEcCtD
Darunavir—Haemoglobin—Fluorouracil—head and neck cancer	0.00337	0.00337	CcSEcCtD
Darunavir—Haemorrhage—Fluorouracil—head and neck cancer	0.00335	0.00335	CcSEcCtD
Darunavir—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00333	0.00333	CcSEcCtD
Darunavir—Paraesthesia—Vinblastine—head and neck cancer	0.00326	0.00326	CcSEcCtD
Darunavir—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00324	0.00324	CcSEcCtD
Darunavir—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00324	0.00324	CcSEcCtD
Darunavir—Liver function test abnormal—Docetaxel—head and neck cancer	0.00323	0.00323	CcSEcCtD
Darunavir—Skin disorder—Hydroxyurea—head and neck cancer	0.00321	0.00321	CcSEcCtD
Darunavir—Dry skin—Docetaxel—head and neck cancer	0.0032	0.0032	CcSEcCtD
Darunavir—Breast disorder—Docetaxel—head and neck cancer	0.00316	0.00316	CcSEcCtD
Darunavir—Anorexia—Hydroxyurea—head and neck cancer	0.00315	0.00315	CcSEcCtD
Darunavir—Decreased appetite—Vinblastine—head and neck cancer	0.00315	0.00315	CcSEcCtD
Darunavir—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00315	0.00315	CcSEcCtD
Darunavir—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00315	0.00315	CcSEcCtD
Darunavir—Nasopharyngitis—Docetaxel—head and neck cancer	0.00313	0.00313	CcSEcCtD
Darunavir—Constipation—Vinblastine—head and neck cancer	0.0031	0.0031	CcSEcCtD
Darunavir—Pain—Vinblastine—head and neck cancer	0.0031	0.0031	CcSEcCtD
Darunavir—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00308	0.00308	CcSEcCtD
Darunavir—Feeling abnormal—Vinblastine—head and neck cancer	0.00299	0.00299	CcSEcCtD
Darunavir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00297	0.00297	CcSEcCtD
Darunavir—Alopecia—Fluorouracil—head and neck cancer	0.00296	0.00296	CcSEcCtD
Darunavir—Dyspnoea—Hydroxyurea—head and neck cancer	0.00295	0.00295	CcSEcCtD
Darunavir—Angina pectoris—Docetaxel—head and neck cancer	0.00294	0.00294	CcSEcCtD
Darunavir—Somnolence—Hydroxyurea—head and neck cancer	0.00294	0.00294	CcSEcCtD
Darunavir—Erythema—Fluorouracil—head and neck cancer	0.00292	0.00292	CcSEcCtD
Darunavir—Dyspepsia—Hydroxyurea—head and neck cancer	0.00291	0.00291	CcSEcCtD
Darunavir—Decreased appetite—Hydroxyurea—head and neck cancer	0.00288	0.00288	CcSEcCtD
Darunavir—Pancytopenia—Docetaxel—head and neck cancer	0.00287	0.00287	CcSEcCtD
Darunavir—Abdominal pain—Vinblastine—head and neck cancer	0.00287	0.00287	CcSEcCtD
Darunavir—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00286	0.00286	CcSEcCtD
Darunavir—Fatigue—Hydroxyurea—head and neck cancer	0.00285	0.00285	CcSEcCtD
Darunavir—Pain—Hydroxyurea—head and neck cancer	0.00283	0.00283	CcSEcCtD
Darunavir—Constipation—Hydroxyurea—head and neck cancer	0.00283	0.00283	CcSEcCtD
Darunavir—Neutropenia—Docetaxel—head and neck cancer	0.00283	0.00283	CcSEcCtD
Darunavir—Weight increased—Docetaxel—head and neck cancer	0.00275	0.00275	CcSEcCtD
Darunavir—Weight decreased—Docetaxel—head and neck cancer	0.00273	0.00273	CcSEcCtD
Darunavir—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00273	0.00273	CcSEcCtD
Darunavir—Anaemia—Fluorouracil—head and neck cancer	0.0027	0.0027	CcSEcCtD
Darunavir—Infestation NOS—Docetaxel—head and neck cancer	0.00269	0.00269	CcSEcCtD
Darunavir—Infestation—Docetaxel—head and neck cancer	0.00269	0.00269	CcSEcCtD
Darunavir—Hypersensitivity—Vinblastine—head and neck cancer	0.00267	0.00267	CcSEcCtD
Darunavir—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00267	0.00267	CcSEcCtD
Darunavir—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00266	0.00266	CcSEcCtD
Darunavir—Renal failure—Docetaxel—head and neck cancer	0.00265	0.00265	CcSEcCtD
Darunavir—Myocardial infarction—Docetaxel—head and neck cancer	0.00264	0.00264	CcSEcCtD
Darunavir—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00264	0.00264	CcSEcCtD
Darunavir—Stomatitis—Docetaxel—head and neck cancer	0.00263	0.00263	CcSEcCtD
Darunavir—Jaundice—Docetaxel—head and neck cancer	0.00263	0.00263	CcSEcCtD
Darunavir—Body temperature increased—Hydroxyurea—head and neck cancer	0.00261	0.00261	CcSEcCtD
Darunavir—Leukopenia—Fluorouracil—head and neck cancer	0.00261	0.00261	CcSEcCtD
Darunavir—Asthenia—Vinblastine—head and neck cancer	0.0026	0.0026	CcSEcCtD
Darunavir—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00255	0.00255	CcSEcCtD
Darunavir—Epistaxis—Docetaxel—head and neck cancer	0.00254	0.00254	CcSEcCtD
Darunavir—Convulsion—Fluorouracil—head and neck cancer	0.00253	0.00253	CcSEcCtD
Darunavir—Chest pain—Fluorouracil—head and neck cancer	0.00248	0.00248	CcSEcCtD
Darunavir—Myalgia—Fluorouracil—head and neck cancer	0.00248	0.00248	CcSEcCtD
Darunavir—Diarrhoea—Vinblastine—head and neck cancer	0.00248	0.00248	CcSEcCtD
Darunavir—Discomfort—Fluorouracil—head and neck cancer	0.00245	0.00245	CcSEcCtD
Darunavir—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00244	0.00244	CcSEcCtD
Darunavir—Haemoglobin—Docetaxel—head and neck cancer	0.00243	0.00243	CcSEcCtD
Darunavir—Haemorrhage—Docetaxel—head and neck cancer	0.00242	0.00242	CcSEcCtD
Darunavir—Hepatitis—Docetaxel—head and neck cancer	0.00242	0.00242	CcSEcCtD
Darunavir—Hypoaesthesia—Docetaxel—head and neck cancer	0.00241	0.00241	CcSEcCtD
Darunavir—Confusional state—Fluorouracil—head and neck cancer	0.0024	0.0024	CcSEcCtD
Darunavir—Dizziness—Vinblastine—head and neck cancer	0.0024	0.0024	CcSEcCtD
Darunavir—Urinary tract disorder—Docetaxel—head and neck cancer	0.00239	0.00239	CcSEcCtD
Darunavir—Oedema peripheral—Docetaxel—head and neck cancer	0.00238	0.00238	CcSEcCtD
Darunavir—Connective tissue disorder—Docetaxel—head and neck cancer	0.00238	0.00238	CcSEcCtD
Darunavir—Asthenia—Hydroxyurea—head and neck cancer	0.00237	0.00237	CcSEcCtD
Darunavir—Urethral disorder—Docetaxel—head and neck cancer	0.00237	0.00237	CcSEcCtD
Darunavir—Nervous system disorder—Fluorouracil—head and neck cancer	0.00233	0.00233	CcSEcCtD
Darunavir—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00233	0.00233	CcSEcCtD
Darunavir—Visual impairment—Docetaxel—head and neck cancer	0.00233	0.00233	CcSEcCtD
Darunavir—Tachycardia—Fluorouracil—head and neck cancer	0.00232	0.00232	CcSEcCtD
Darunavir—Vomiting—Vinblastine—head and neck cancer	0.00231	0.00231	CcSEcCtD
Darunavir—Erythema multiforme—Docetaxel—head and neck cancer	0.00229	0.00229	CcSEcCtD
Darunavir—Headache—Vinblastine—head and neck cancer	0.00227	0.00227	CcSEcCtD
Darunavir—Anorexia—Fluorouracil—head and neck cancer	0.00227	0.00227	CcSEcCtD
Darunavir—Diarrhoea—Hydroxyurea—head and neck cancer	0.00226	0.00226	CcSEcCtD
Darunavir—Eye disorder—Docetaxel—head and neck cancer	0.00226	0.00226	CcSEcCtD
Darunavir—Flushing—Docetaxel—head and neck cancer	0.00224	0.00224	CcSEcCtD
Darunavir—Cardiac disorder—Docetaxel—head and neck cancer	0.00224	0.00224	CcSEcCtD
Darunavir—Angiopathy—Docetaxel—head and neck cancer	0.00219	0.00219	CcSEcCtD
Darunavir—Dizziness—Hydroxyurea—head and neck cancer	0.00219	0.00219	CcSEcCtD
Darunavir—Immune system disorder—Docetaxel—head and neck cancer	0.00218	0.00218	CcSEcCtD
Darunavir—Mediastinal disorder—Docetaxel—head and neck cancer	0.00218	0.00218	CcSEcCtD
Darunavir—Chills—Docetaxel—head and neck cancer	0.00217	0.00217	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00217	0.00217	CcSEcCtD
Darunavir—Nausea—Vinblastine—head and neck cancer	0.00215	0.00215	CcSEcCtD
Darunavir—Insomnia—Fluorouracil—head and neck cancer	0.00215	0.00215	CcSEcCtD
Darunavir—Paraesthesia—Fluorouracil—head and neck cancer	0.00214	0.00214	CcSEcCtD
Darunavir—Alopecia—Docetaxel—head and neck cancer	0.00214	0.00214	CcSEcCtD
Darunavir—Dyspnoea—Fluorouracil—head and neck cancer	0.00212	0.00212	CcSEcCtD
Darunavir—Mental disorder—Docetaxel—head and neck cancer	0.00212	0.00212	CcSEcCtD
Darunavir—Somnolence—Fluorouracil—head and neck cancer	0.00212	0.00212	CcSEcCtD
Darunavir—Erythema—Docetaxel—head and neck cancer	0.00211	0.00211	CcSEcCtD
Darunavir—Malnutrition—Docetaxel—head and neck cancer	0.00211	0.00211	CcSEcCtD
Darunavir—Vomiting—Hydroxyurea—head and neck cancer	0.0021	0.0021	CcSEcCtD
Darunavir—Dyspepsia—Fluorouracil—head and neck cancer	0.0021	0.0021	CcSEcCtD
Darunavir—Rash—Hydroxyurea—head and neck cancer	0.00209	0.00209	CcSEcCtD
Darunavir—Dermatitis—Hydroxyurea—head and neck cancer	0.00208	0.00208	CcSEcCtD
Darunavir—Headache—Hydroxyurea—head and neck cancer	0.00207	0.00207	CcSEcCtD
Darunavir—Decreased appetite—Fluorouracil—head and neck cancer	0.00207	0.00207	CcSEcCtD
Darunavir—Dysgeusia—Docetaxel—head and neck cancer	0.00206	0.00206	CcSEcCtD
Darunavir—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00206	0.00206	CcSEcCtD
Darunavir—Pain—Fluorouracil—head and neck cancer	0.00204	0.00204	CcSEcCtD
Darunavir—Muscle spasms—Docetaxel—head and neck cancer	0.00202	0.00202	CcSEcCtD
Darunavir—Nausea—Hydroxyurea—head and neck cancer	0.00196	0.00196	CcSEcCtD
Darunavir—Feeling abnormal—Fluorouracil—head and neck cancer	0.00196	0.00196	CcSEcCtD
Darunavir—Anaemia—Docetaxel—head and neck cancer	0.00195	0.00195	CcSEcCtD
Darunavir—Urticaria—Fluorouracil—head and neck cancer	0.00189	0.00189	CcSEcCtD
Darunavir—Syncope—Docetaxel—head and neck cancer	0.00189	0.00189	CcSEcCtD
Darunavir—Leukopenia—Docetaxel—head and neck cancer	0.00188	0.00188	CcSEcCtD
Darunavir—Body temperature increased—Fluorouracil—head and neck cancer	0.00188	0.00188	CcSEcCtD
Darunavir—Palpitations—Docetaxel—head and neck cancer	0.00186	0.00186	CcSEcCtD
Darunavir—Loss of consciousness—Docetaxel—head and neck cancer	0.00185	0.00185	CcSEcCtD
Darunavir—Cough—Docetaxel—head and neck cancer	0.00184	0.00184	CcSEcCtD
Darunavir—Convulsion—Docetaxel—head and neck cancer	0.00182	0.00182	CcSEcCtD
Darunavir—Hypertension—Docetaxel—head and neck cancer	0.00182	0.00182	CcSEcCtD
Darunavir—Arthralgia—Docetaxel—head and neck cancer	0.00179	0.00179	CcSEcCtD
Darunavir—Chest pain—Docetaxel—head and neck cancer	0.00179	0.00179	CcSEcCtD
Darunavir—Myalgia—Docetaxel—head and neck cancer	0.00179	0.00179	CcSEcCtD
Darunavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00178	0.00178	CcSEcCtD
Darunavir—Hypersensitivity—Fluorouracil—head and neck cancer	0.00175	0.00175	CcSEcCtD
Darunavir—Dry mouth—Docetaxel—head and neck cancer	0.00175	0.00175	CcSEcCtD
Darunavir—Confusional state—Docetaxel—head and neck cancer	0.00173	0.00173	CcSEcCtD
Darunavir—Shock—Docetaxel—head and neck cancer	0.00169	0.00169	CcSEcCtD
Darunavir—Nervous system disorder—Docetaxel—head and neck cancer	0.00169	0.00169	CcSEcCtD
Darunavir—Pruritus—Fluorouracil—head and neck cancer	0.00168	0.00168	CcSEcCtD
Darunavir—Thrombocytopenia—Docetaxel—head and neck cancer	0.00168	0.00168	CcSEcCtD
Darunavir—Tachycardia—Docetaxel—head and neck cancer	0.00168	0.00168	CcSEcCtD
Darunavir—Skin disorder—Docetaxel—head and neck cancer	0.00167	0.00167	CcSEcCtD
Darunavir—Anorexia—Docetaxel—head and neck cancer	0.00164	0.00164	CcSEcCtD
Darunavir—Diarrhoea—Fluorouracil—head and neck cancer	0.00163	0.00163	CcSEcCtD
Darunavir—Dizziness—Fluorouracil—head and neck cancer	0.00157	0.00157	CcSEcCtD
Darunavir—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00157	0.00157	CcSEcCtD
Darunavir—Insomnia—Docetaxel—head and neck cancer	0.00155	0.00155	CcSEcCtD
Darunavir—Paraesthesia—Docetaxel—head and neck cancer	0.00154	0.00154	CcSEcCtD
Darunavir—Dyspnoea—Docetaxel—head and neck cancer	0.00153	0.00153	CcSEcCtD
Darunavir—Somnolence—Docetaxel—head and neck cancer	0.00153	0.00153	CcSEcCtD
Darunavir—Vomiting—Fluorouracil—head and neck cancer	0.00151	0.00151	CcSEcCtD
Darunavir—Dyspepsia—Docetaxel—head and neck cancer	0.00151	0.00151	CcSEcCtD
Darunavir—Rash—Fluorouracil—head and neck cancer	0.0015	0.0015	CcSEcCtD
Darunavir—Dermatitis—Fluorouracil—head and neck cancer	0.0015	0.0015	CcSEcCtD
Darunavir—Decreased appetite—Docetaxel—head and neck cancer	0.00149	0.00149	CcSEcCtD
Darunavir—Headache—Fluorouracil—head and neck cancer	0.00149	0.00149	CcSEcCtD
Darunavir—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00148	0.00148	CcSEcCtD
Darunavir—Fatigue—Docetaxel—head and neck cancer	0.00148	0.00148	CcSEcCtD
Darunavir—Pain—Docetaxel—head and neck cancer	0.00147	0.00147	CcSEcCtD
Darunavir—Constipation—Docetaxel—head and neck cancer	0.00147	0.00147	CcSEcCtD
Darunavir—Feeling abnormal—Docetaxel—head and neck cancer	0.00142	0.00142	CcSEcCtD
Darunavir—Nausea—Fluorouracil—head and neck cancer	0.00141	0.00141	CcSEcCtD
Darunavir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00141	0.00141	CcSEcCtD
Darunavir—Body temperature increased—Docetaxel—head and neck cancer	0.00136	0.00136	CcSEcCtD
Darunavir—Abdominal pain—Docetaxel—head and neck cancer	0.00136	0.00136	CcSEcCtD
Darunavir—Hypersensitivity—Docetaxel—head and neck cancer	0.00127	0.00127	CcSEcCtD
Darunavir—Asthenia—Docetaxel—head and neck cancer	0.00123	0.00123	CcSEcCtD
Darunavir—Pruritus—Docetaxel—head and neck cancer	0.00122	0.00122	CcSEcCtD
Darunavir—Diarrhoea—Docetaxel—head and neck cancer	0.00118	0.00118	CcSEcCtD
Darunavir—Dizziness—Docetaxel—head and neck cancer	0.00114	0.00114	CcSEcCtD
Darunavir—Vomiting—Docetaxel—head and neck cancer	0.00109	0.00109	CcSEcCtD
Darunavir—Rash—Docetaxel—head and neck cancer	0.00108	0.00108	CcSEcCtD
Darunavir—Dermatitis—Docetaxel—head and neck cancer	0.00108	0.00108	CcSEcCtD
Darunavir—Headache—Docetaxel—head and neck cancer	0.00108	0.00108	CcSEcCtD
Darunavir—Nausea—Docetaxel—head and neck cancer	0.00102	0.00102	CcSEcCtD
